# Topiramate's Effects on Heavy Drinking

> **NCT02074904** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 1 (actual)

## Conditions studied

- Alcohol Drinking

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02074904
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo controlled, double-blind, trial of topiramate in heavy drinkers.
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074904, "Topiramate's Effects on Heavy Drinking". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02074904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*